Cargando…
Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met
BACKGROUND: In the pediatric population, infections by methicillin-resistant Staphylococcus aureus (MRSA) are associated with significant morbidity and hospital costs. Vancomycin is a glycopeptide antibiotic, widely used for the treatment of serious infections by Gram-positive microorganisms, especi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639923/ https://www.ncbi.nlm.nih.gov/pubmed/31319831 http://dx.doi.org/10.1186/s12887-019-1602-8 |
_version_ | 1783436557342998528 |
---|---|
author | Maloni, Talita Muniz Belucci, Talita Rantin Malagutti, Sandra Regina Furtado, Guilherme Henrique Campos |
author_facet | Maloni, Talita Muniz Belucci, Talita Rantin Malagutti, Sandra Regina Furtado, Guilherme Henrique Campos |
author_sort | Maloni, Talita Muniz |
collection | PubMed |
description | BACKGROUND: In the pediatric population, infections by methicillin-resistant Staphylococcus aureus (MRSA) are associated with significant morbidity and hospital costs. Vancomycin is a glycopeptide antibiotic, widely used for the treatment of serious infections by Gram-positive microorganisms, especially MRSA. It is recommended to keep the serum level of vancomycin between 10 and 20 mg/L, that correlates with AUC/MIC > 400 in adults. This pharmacodynamic target is extrapolated to pediatric patients despite the lack of similar evidence. However, recent studies suggest that serum levels between 7 and 10 mg/L are predictive of reaching the pharmacodynamic target in this population. In spite of widespread use, ideal information about dosage for the pediatric population remains limited. METHODS: A retrospective study was conducted in patients admitted to the Pediatric Intensive Care Unit during the period between January 01, 2008 to December 31, 2014. We investigated variables such as age, positive fluid balance and use of vasoactive drugs on the ability of these patients to achieve the proposed recommended serum level target and the vancomycin serum levels. RESULTS: Our study showed that only 26% of children reached the 10–20 mg/L serum level whereas the 7–20 mg/L serum level was reached by 51% of patients. CONCLUSIONS: We observed no evidence of a significant association between the inadequacy of serum level and age. The positive fluid balance also had no influence on the vancomycin serum level but patients using vasoactive drugs had a greater serum level adequacy than patients not using vasoactive drugs. |
format | Online Article Text |
id | pubmed-6639923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66399232019-07-29 Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met Maloni, Talita Muniz Belucci, Talita Rantin Malagutti, Sandra Regina Furtado, Guilherme Henrique Campos BMC Pediatr Research Article BACKGROUND: In the pediatric population, infections by methicillin-resistant Staphylococcus aureus (MRSA) are associated with significant morbidity and hospital costs. Vancomycin is a glycopeptide antibiotic, widely used for the treatment of serious infections by Gram-positive microorganisms, especially MRSA. It is recommended to keep the serum level of vancomycin between 10 and 20 mg/L, that correlates with AUC/MIC > 400 in adults. This pharmacodynamic target is extrapolated to pediatric patients despite the lack of similar evidence. However, recent studies suggest that serum levels between 7 and 10 mg/L are predictive of reaching the pharmacodynamic target in this population. In spite of widespread use, ideal information about dosage for the pediatric population remains limited. METHODS: A retrospective study was conducted in patients admitted to the Pediatric Intensive Care Unit during the period between January 01, 2008 to December 31, 2014. We investigated variables such as age, positive fluid balance and use of vasoactive drugs on the ability of these patients to achieve the proposed recommended serum level target and the vancomycin serum levels. RESULTS: Our study showed that only 26% of children reached the 10–20 mg/L serum level whereas the 7–20 mg/L serum level was reached by 51% of patients. CONCLUSIONS: We observed no evidence of a significant association between the inadequacy of serum level and age. The positive fluid balance also had no influence on the vancomycin serum level but patients using vasoactive drugs had a greater serum level adequacy than patients not using vasoactive drugs. BioMed Central 2019-07-18 /pmc/articles/PMC6639923/ /pubmed/31319831 http://dx.doi.org/10.1186/s12887-019-1602-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Maloni, Talita Muniz Belucci, Talita Rantin Malagutti, Sandra Regina Furtado, Guilherme Henrique Campos Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title | Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title_full | Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title_fullStr | Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title_full_unstemmed | Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title_short | Describing vancomycin serum levels in pediatric intensive care unit (ICU) patients: are expected goals being met |
title_sort | describing vancomycin serum levels in pediatric intensive care unit (icu) patients: are expected goals being met |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639923/ https://www.ncbi.nlm.nih.gov/pubmed/31319831 http://dx.doi.org/10.1186/s12887-019-1602-8 |
work_keys_str_mv | AT malonitalitamuniz describingvancomycinserumlevelsinpediatricintensivecareuniticupatientsareexpectedgoalsbeingmet AT beluccitalitarantin describingvancomycinserumlevelsinpediatricintensivecareuniticupatientsareexpectedgoalsbeingmet AT malaguttisandraregina describingvancomycinserumlevelsinpediatricintensivecareuniticupatientsareexpectedgoalsbeingmet AT furtadoguilhermehenriquecampos describingvancomycinserumlevelsinpediatricintensivecareuniticupatientsareexpectedgoalsbeingmet |